↓ Skip to main content

Lessons learned from the DAPA-HF trial concerning the mechanisms of benefit of SGLT2 inhibitors on heart failure events in the context of other large-scale trials nearing completion

Overview of attention for article published in Cardiovascular Diabetology, October 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter
23 X users
patent
3 patents

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
133 Mendeley